title: [Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease].
authors.forename: F J
authors.initials: FJ
authors.lastname: Neumann
authors.forename: C
authors.initials: C
authors.lastname: Diehm
authors.forename: U
authors.initials: U
authors.lastname: Müller-Bühl
authors.forename: T
authors.initials: T
authors.lastname: Weiss
authors.forename: R
authors.initials: R
authors.lastname: Zimmermann
authors.forename: H
authors.initials: H
authors.lastname: Tillmanns
authors.forename: W
authors.initials: W
authors.lastname: Kübler
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007958:Leukocyte Count / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology
chemical_list: D000527:Alprostadil
vernacular_title: Einfluss von Prostaglandin E1 auf Funktion und Verformbarkeit neutrophiler Granulozyten bei Patienten mit peripherer arterieller Verschlusskrankheit im Stadium IV.